Conference Documentation: COPD: Novel Therapeutics and Management
SMi is proud to to present it's 6th annual conference on COPD taking place from the 20th - 21st October 2014 in Central London. This year's conference will follow and expand on last year's event and will provide the audience with the latest updates and developemnts in the COPD industry both from pharmaceutical companies and academia alike.
According to the World Health Organisation (WHO), COPD is set to become the third leading cause of death worldwide by 2030. There is therefore an imperative need for all stakeholders to come together in order to tackle this disease. With the market for COPD growing year on year, new drug/compound development, innovation and management strategies are required to combat this disease. This conference will therefore bring togther major industry stakeholders within COPD to discuss, evaluate and review the latest development in the market.
This year's agenda will start with an overview of COPD while addressing the regulatory aspects and looking at market access. The focus will then be on managing exacerbation and comorbidities, enuring a successful clinical trial design and challenges in drug development. New sessions will be added, namely patient care, anxiety and depression in COPD, COPD and phenotyping and telehealth.
Hear the story from the other side: Jim & Mary Nelson have kindly accepted to share their story and battle with COPD. Don't miss the oppportunity to gain more insight from them!
Electronic Access - Single User Fulfilled By Publisher